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being siRNAs, but still has its own limitations like silencing off
targets and no access to nuclear genes. Hence among alterna-
tives, catalytic nucleic acids are the best candidates to bet upon.
The aim of this study is to use the catalytic nucleic acids like
Ribozymes and DNAzymes as a candidate to have a control on the
replication of inﬂuenza virus in the host cells.
Methods: The M1 gene of A/PR/8/34 (H1N1)) strains were cloned
in pcDNA 3. The computer based secondary structures of RNA
were analyzed to design the DNAzymes with 10-23 catalytic
motifs and the hammerhead Ribozymes. The DNAzymes and
Ribozymes were also used in combination.
Results: The DNAzymes were able to cleave the M1 RNA at 137
nt position whereas Ribozymes targeted at163 nt position in the
same target. These catalytic nucleic acids were highly efﬁcient
under the simulated physiological conditions. When DNAzymes
and Ribozymes were used in combination the cleavage was en-
hanced as compared to when they were used alone. Further
an siRNA-Ribozyme construct was also designed. We have also
demonstrated the modulation of the expression of target gene in
controlled manner at RNA level by RT-PCR and FACs.
Conclusion: This combinatorial strategy can be used to de-
sign multi target DNA-enzymes and Ribozymes to delay the
appearance of escape mutants because of the low probability of
simultaneous mutations in both the target RNA sites.
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OL-048 P-glycoprotein regulation in Hep3B cells by
polyprenol could decrease the risk of
hepatocarcinogenesis in HBV
Sergejs Kuznecovs*, Ivans Kuznecovs. Cancer Research
Laboratory
Background: Over-expression of P-glycoprotein (Pgp) is associ-
ated with liver cancer development from HBV. The resent results
are also in favour of the idea that glycoprotein synthesis in ma-
lignant tissues is limited by Dolichyl Phosphate (DolP). The aim of
the present study was to investigate the effect of polyprenol (PP)
which provides a DolP substitute in regulation of N-glycosylation
on Pgp over-expression in the development of liver cancer in HBV
infection.
Methods: Human hepatocytes, infected with HBV and human
hepatocarcinoma HEP 3B cell line were used. Pgp was assessed
by an immunohistochemical technique. DolP fractions were anal-
ysed by HPLC methods.
Result: It is conﬁrmed that plasmatic membrans of hepatocytes-
cells contain 7,9–9,4% of Pgp (the total protein amount) as a
resistance marker. HBV infected cells differ from normal hepato-
cytes in Pgp content by 4-5 times and Hep3B cells differ by 10-12
times The study showed 5-fold DolP decrease in HBV infected
cells and 10-fold DolP decrease in Hep3B cells. The investigations
demonstrate that the situation can be changed by treatment with
DolP and PP. The DolP concentration in HBV infected hepatocytes
was returned to the normal level. It is established that DolP in
the concentration 10-6M aid 6-8-fold reducing Pgp in membranes
of HBV infected cells.
Conclusion: These results indicate that noncontrollable accu-
mulation of Pgp in HBV infected cells can be overcomed using
stimulation with DolP substitution. Polyprenol usage can open up
possibilities in liver cancer prevention in HBV infection.
OL-049 T cell immunoglobulin- and
mucin-domain-containing molecule-3 (Tim-3)
mediates natural killer cell suppression in
chronic hepatitis B
Ying Ju*,1, Nan Hou1, Jing Meng1, Xiaoyan Wang1,
Xiaoning Zhang1, Xiaoyan Wang2, Jinjin Wang1, Fang Luan1,
Wei Shi 1, Faliang Zhu1, Chun Guo1, Lining Zhang1,
Wensheng Sun1, Xiaohong Liang1, Lifen Gao1, Chunhong Ma1,3.
1Institute of Immunology; 2Infectious Disease Hospital; 3The Key
Laboratory for Experimental Teratology of the Ministry of
Education
Background/Aims: T cell immunoglobulin- and mucin-domain-
containing molecule-3 (Tim-3) has been shown to inﬂuence
autoimmune diseases, including diabetes and multiple sclerosis,
but its role in viral infection has not been well-deﬁned. In this
study, we investigated the expression and regulatory function of
Tim-3 on natural killer (NK) cells in chronic Hepatitis B (CHB).
Methods: Seventy-six CHB patients, 38 healthy controls, and
18 patients with fatty liver disease (FLD) were studied. Tim-3
expression was detected in both peripheral blood mononuclear
cells (PBMCs) and liver inﬁltrating lymphocytes (LILs) by real-
time RT-PCR, ﬂow cytometric analysis and immunohistochemical
analysis. The roles of Tim-3 in NK cell were detected by ﬂow
cytometric analysis and cytotoxicity assay.
Results: We found the increased Tim-3 expression in PBMCs, LILs
and circulating NK cells from CHB. Increased Tim-3 expression
was also detected on cultured NK92 cells transfected with HBV
expression vector (pCDNA-1.1HBV) and hepatic NK cells from
HBV transgenic mice. Importantly, upon blocking Tim-3 with
a speciﬁc antibody, NK92 cells showed increased cytotoxicity
against HepG2 and HepG2.2.15 cells, accompanied with elevated
interferon gamma (IFN-γ) production. Similarly, enhanced cyto-
toxicity was also observed in PBMCs from CHB patients treated
with anti-Tim-3.
Conclusion: HBV infection upregulates Tim-3 expression on NK
cells, which may in turn suppress NK cell function during CHB.
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Objectives: To study the quantity and quality of HBV-speciﬁc T
cells in chronic hepatitis B (CHB) patients with different HBeAg
status, and to investigate the extent of liver damage.
Methods: The serum HBV markers, liver damage, the frequency
and Foxp3 expression of CD4+CD25+ regulatory T cells (Treg),
and the expression levels of PD-1, CTLA-4 on HBV-speciﬁc T cells
were measured. HBV antigens speciﬁc T-cell responses, with or
without anti-PD-1 mAb and/or anti-CTLA-4 mAb blocking, were
also tested.
Results: The demographic characters, serum ALT levels, the fre-
quency and Foxp3 expression of Treg were similar between two
groups, and the serum HBV DNA levels were higher in HBeAg(+)
patients. The liver necroinﬂammation was comparatively severe
in HBeAg(–) patients (P=0.052), while the median percentage of
liver cirrhosis was much higher in HBeAg(+) patients. The differ-
ence of HBV-speciﬁc T-cell frequency was not signiﬁcant, whereas
the expression levels of PD-1 and CTLA-4 on HBV-pentamer(+)
T cells were higher in HBeAg(+) patients. Combined using of
anti-PD-L1 and anti-CTLA-4 mAb could signiﬁcantly increase the
cellular proliferation in both groups, and markedly enhanced the
IFN-γ production in HBeAg(+) patients.
Conclusion: The persistency of HBeAg could induce higher ex-
